SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-019742
Filing Date
2021-08-12
Accepted
2021-08-12 17:01:28
Documents
78
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cenb20210630_10q.htm   iXBRL 10-Q 1198620
2 EXHIBIT 31.1 ex_271517.htm EX-31.1 10355
3 EXHIBIT 31.2 ex_271518.htm EX-31.2 9333
4 EXHIBIT 32.1 ex_271519.htm EX-32.1 4525
5 EXHIBIT 32.2 ex_271520.htm EX-32.2 4578
  Complete submission text file 0001437749-21-019742.txt   6375293

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cenb-20210630.xsd EX-101.SCH 72884
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cenb-20210630_cal.xml EX-101.CAL 37840
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cenb-20210630_def.xml EX-101.DEF 489352
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cenb-20210630_lab.xml EX-101.LAB 359744
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cenb-20210630_pre.xml EX-101.PRE 512440
11 EXTRACTED XBRL INSTANCE DOCUMENT cenb20210630_10q_htm.xml XML 976467
Mailing Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9
Business Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55557 | Film No.: 211168523
SIC: 2834 Pharmaceutical Preparations